Ohio Public Employees Retirement System (OPERS)
FATE icon

Ohio Public Employees Retirement System (OPERS)’s Fate Therapeutics FATE Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-113,655
Closed -$143K – 2329
2025
Q3 		$143K Hold
113,655
– – ﹤0.01% 1732
2025
Q2 		$127K Sell
113,655
-49,000
-30% -$57K ﹤0.01% 1736
2025
Q1 		$129K Buy
162,655
+73,889
+83% +$90.6K ﹤0.01% 1722
2024
Q4 		$146K Sell
88,766
-46,100
-34% -$116K ﹤0.01% 1724
2024
Q3 		$472K Sell
134,866
-4,500
-3% -$17.5K ﹤0.01% 1410
2024
Q2 		$457K Sell
139,366
-8,433
-6% -$36.9K ﹤0.01% 1287
2024
Q1 		$1.08M Sell
147,799
-6,379
-4% -$39.5K ﹤0.01% 1114
2023
Q4 		$577K Hold
154,178
– – ﹤0.01% 1244
2023
Q3 		$327K Buy
154,178
+19,775
+15% +$65.5K ﹤0.01% 1295
2023
Q2 		$640K Buy
+134,403
New +$742K ﹤0.01% 1238

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s FATE Position: Q4 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Fate Therapeutics (FATE) in Q4 2025, closing a stake of 113,655 shares — an estimated $143K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in FATE in Q2 2023 and held it in 10 quarters. The position peaked at $1.08M in Q1 2024. 146 funds tracked by Wall St. Rank hold FATE as of Q4 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Fate Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 113,655 Fate Therapeutics shares in Q4 2025, an estimated $143K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Fate Therapeutics in Q2 2023 and held it in 10 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Fate Therapeutics position peaked at $1.08M in Q1 2024.
  • 146 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2025, filed 17 Feb 2026.